Can EGCG Alleviate Symptoms of Down Syndrome by Altering Proteolytic Activity?
Ontology highlight
ABSTRACT: Down syndrome (DS), also known as "trisomy 21", is a genetic disorder caused by the presence of all or part of a third copy of chromosome 21. Silencing these extra genes is beyond existing technology and seems to be impractical. A number of pharmacologic options have been proposed to change the quality of life and lifespan of individuals with DS. It was reported that treatment with epigallocatechin gallate (EGCG) improves cognitive performance in animal models and in humans, suggesting that EGCG may alleviate symptoms of DS. Traditionally, EGCG has been associated with the ability to reduce dual specificity tyrosine phosphorylation regulated kinase 1A activity, which is overexpressed in trisomy 21. Based on the data available in the literature, we propose an additional way in which EGCG mi
SUBMITTER: Wyganowska-Swiatkowska M
PROVIDER: S-EPMC5796196 | biostudies-literature | 2018 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA